|
|
Dr. Samuel Ludwin went to medical school at the University of Witwatersrand, Johannesburg, South Africa, and followed this with residency and fellowship training in Pathology and Neuropathology at Stanford University in California. Since 1975 he has been at Queen's University and Kingston General Hospital where he was a Professor of Pathology and Molecular Medicine until July 2010. He has specialized in research, teaching and the clinical practice of Neuropathology. At Queen's, Dr. Ludwin also served as Associate Dean (Research) in the Faculty of Health Sciences, and as Vice-President (Research Development) Kingston General and Hotel Dieu Hospitals. His major investigative interest has been in the field of Multiple Sclerosis, in which he has carried out both basic experimental research and clinical studies. His research work has been on around mechanisms of remyelination and demyelination as well as oligodendrocyte and astrocyte behaviour in clinical Multiple Sclerosis and its models. In July 2010, he became Professor Emeritus at Queen's University.
|